Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Inferring genetic variant causal network by leveraging pleiotropy

Martin Tournaire, Asma Nouira, View ORCID ProfileYves Rozenholc, View ORCID ProfileMarie Verbanck
doi: https://doi.org/10.1101/2024.06.01.24308193
Martin Tournaire
1UR 7537 BioSTM, Biostatistique, Traitement et Modélisation des données biologiques, Université Paris Cité
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asma Nouira
1UR 7537 BioSTM, Biostatistique, Traitement et Modélisation des données biologiques, Université Paris Cité
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Rozenholc
1UR 7537 BioSTM, Biostatistique, Traitement et Modélisation des données biologiques, Université Paris Cité
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yves Rozenholc
Marie Verbanck
1UR 7537 BioSTM, Biostatistique, Traitement et Modélisation des données biologiques, Université Paris Cité
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie Verbanck
  • For correspondence: marie.verbanck{at}u-paris.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Genetic variants have robustly been associated with multiple traits through genome-wide association studies (GWAS) over the past two decades. However, pinpointing the true causal genetic variant and its biological mechanism is still a considerable challenge. Recently, much concerned has been raised about the weak overlap between expression quantitative trait loci or DNA methylation with GWAS variants, when these very same molecular phenotypes have been routinely used to interpret GWAS variants. Therefore, we propose to takes the opposite approach to conventional methods and to infer variant causal networks by leveraging pleiotropy. We introduce PRISM (Pleiotropic Relationships to Infer the SNP Model) that aims to distinguish between true direct effects and pleiotropic effects in order to infer a causal network for each genetic variant. The fundamental principle of PRISM is to reassess GWAS associations to test for the consistency of a given variant-trait effect in the pleiotropic context of the other traits. PRISM clusters significant genetic variant effects in 3 categories: trait-mediated, confounder-mediated, and direct effects. By cross-referencing the information on all traits, a causal network is built for each genetic variant. On simulations, PRISM was able to recover direct effects with high precision in complex networks of traits. Then, we applied PRISM to a set of 61 heritable traits and diseases, using GWAS summary statistics from the UK Biobank. Interestingly, direct effects represent less than 13% of total significant effects, while vertical and confounding effects represent 43% and 44% respectively. Direct variants were largely enriched in per-variant heritability compared to GWAS-significant variants and pleiotropic variants. Pathways from direct variants lead to higher enrichment than GWAS variants. PRISM was able to pinpoint direct variants mapped to more trait-specific genes than GWAS, and the PRISM gene-trait network appeared disentangled and more relevant compared to the GWAS gene-trait network. Finally, we could show the concordance of the causal networks inferred by PRISM with some networks for a panel of validated variants from the literature.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MV is supported by the French National Research Agency (ANR) (ANR-21-CE45-0023-01).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used only openly available human data in the form of summary statistics from the UK Biobank.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

PRISM is implemented in R and a user-friendly tutorial can be found on github. As long as GWAS summary statistics are available and the studied variants are mapped in HapMap3, it is possible to compute any network of traits of interest to distinguish direct variants from vertical and network variants. PRISM results are easily accessible through an online user-friendly interface. We developed a ShinyR interface, freely available online, to display PRISM results on our network of 61 highly heritable traits. Results can be visualized at the trait level. It is also possible to display the pleiotropic network of a genetic variant of interest.

https://github.com/martintnr/PRISM

https://verbam01.shinyapps.io/PRISM/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 03, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Inferring genetic variant causal network by leveraging pleiotropy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Inferring genetic variant causal network by leveraging pleiotropy
Martin Tournaire, Asma Nouira, Yves Rozenholc, Marie Verbanck
medRxiv 2024.06.01.24308193; doi: https://doi.org/10.1101/2024.06.01.24308193
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Inferring genetic variant causal network by leveraging pleiotropy
Martin Tournaire, Asma Nouira, Yves Rozenholc, Marie Verbanck
medRxiv 2024.06.01.24308193; doi: https://doi.org/10.1101/2024.06.01.24308193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)